Esteemed vascular surgeon brings 10+ years of experience to patients in lower Fairfield County DARIEN, Conn.–(BUSINESS WIRE)–Vascular Care Connecticut, a state-of-the art practice committed to the prevention, diagnosis and treatment of vascular disease, is pleased to announce that Ksenia Orlova, MD, PhD, joined the Darien, Conn. center. Dr. Orlova brings […]
Financial
Sequana Medical announces 2021 Full Year Results and 2022 Outlook
alfapump® in liver disease Positive results from second interim analysis of POSEIDON pivotal study; encouraging survival data at 12 months vs. published literature Patient enrolment and implants completed; primary endpoint on track for Q4 2022 FDA regulatory submission planned for mid-2023 DSR® in heart failure RED DESERT study demonstrated safety, cardio-renal benefit and long-term improvement in diuretic response SAHARA DESERT study interim data shows ability […]
Integer Holdings Corporation Acquires Aran Biomedical
~ Acquisition brings highly differentiated, proprietary biomaterial technologies for implantable cardiovascular devices to enable our customers’ innovation ~ PLANO, Texas, April 07, 2022 (GLOBE NEWSWIRE) — Today, Integer Holdings Corporation (NYSE: ITGR) announced the acquisition of Connemara Biomedical Holdings Teoranta, including its operating subsidiaries Aran Biomedical and Proxy Biomedical (collectively […]
AngioDynamics Reports Fiscal 2022 Third Quarter Financial Results; Reaffirms Fiscal Year 2022 Guidance
Fiscal 2022 Third Quarter Highlights Net sales of $74.0 million increased 3.9% compared to the prior-year quarter Med Tech grew 28.6% and Med Device declined 2.8% year over year Gross margin of 52.2% declined 190 basis points year over year GAAP loss per share of $0.13 and adjusted earnings per […]
CytoSorbents Receives Approximately $740,000 from the New Jersey Business Tax Certificate Transfer Program
MONMOUTH JUNCTION, N.J., April 7, 2022 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced that it has received approximately $740,000, net of transactions costs, in cash proceeds from the sale of its 2020 Net Operating Loss (NOL) and […]
LianBio Appoints Wei Wei Chen to Board of Directors
SHANGHAI and PRINCETON, N.J., April 07, 2022 (GLOBE NEWSWIRE) — LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced the appointment of Wei Wei Chen to the company’s Board of Directors. “I am pleased to welcome Wei […]
Gradient Denervation Technologies Announces Appointment of Martin Grasse as Chief Executive Officer
PARIS, FRANCE / ACCESSWIRE / April 7, 2022 / Gradient Denervation Technologies, a Paris-based medical device company developing a minimally-invasive solution for the treatment of heart failure patients with pulmonary hypertension, announced today the appointment of Martin Grasse as Chief Executive Officer. With over 15 years in the medical device industry, […]
Karoo Health Receives Seed Funding from Panoramic Ventures and FirstMile Ventures to Reimagine Cardiovascular Care
Investment to Support Company’s Engagement with Health Plans and Self-Insured Employers to Provide Tech-Enabled Value-Based Cardiology Solutions AUSTIN, Texas and ALBUQUERQUE, N.M., April 6, 2022 /PRNewswire/ — Karoo Health, a leader in tech-enabled value-based cardiovascular care solutions, today announced it closed a significant seed funding round. The investment will allow Karoo Health to bring its […]
Flow Therapy Adds World-Renowned Cardiologist Timothy D. Henry to Board of Directors
FORT WORTH, Texas, April 06, 2022 (GLOBE NEWSWIRE) — World-renowned cardiologist Timothy D. Henry, MD, FACC, MSCAI, has joined Flow Therapy’s Board of Directors. Dr. Henry is the Lindner Family Distinguished Chair in Clinical Research and Medical Director of The Carl and Edyth Lindner Center for Research at The Christ Hospital […]
Cardior Appoints Dr. Russell Greig as Independent Chairman of the Board
HANOVER, Germany–(BUSINESS WIRE)–Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the appointment of Dr. Russell Greig, as independent Chairman of its Board of Directors. Dr. Greig brings more than 35 years of experience in the pharmaceutical industry from GlaxoSmithKline, with […]



